Alyeska Investment Group, L.P. - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2015. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q4 2017$18,732,000
+97.8%
1,125,047
+141.2%
0.15%
+109.9%
Q3 2017$9,470,000
-62.3%
466,515
-56.0%
0.07%
-69.5%
Q3 2016$25,146,000
-42.8%
1,061,001
-30.4%
0.23%
-43.6%
Q2 2016$43,965,000
+12.6%
1,525,505
+25.1%
0.41%
+15.0%
Q1 2016$39,035,000
-25.2%
1,219,074
-0.1%
0.36%
-35.3%
Q4 2015$52,191,000
+96.6%
1,220,553
+61.9%
0.56%
+77.9%
Q3 2015$26,551,000754,0890.31%
Other shareholders
IMPAX LABORATORIES INC shareholders Q4 2015
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 1,032,187$24,463,0008.84%
Asymmetry Capital Management, L.P. 164,156$3,890,0006.76%
Hound Partners 6,204,588$147,049,0003.96%
Sivik Global Healthcare LLC 130,000$3,081,0001.55%
Tradewinds Global Investors, LLC 49,661$1,177,0001.45%
SECTOR GAMMA AS 409,964$7,318,0001.28%
Orbimed Advisors 3,787,500$89,764,0001.02%
Iguana Healthcare Management, LLC 200,000$4,740,0000.84%
Seven Bridges Advisors LLC 37,409$887,0000.79%
Penn Capital Management Company, LLC 454,597$10,808,0000.73%
View complete list of IMPAX LABORATORIES INC shareholders